Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | Apr 30, 2026 | Oct 31, 2025 | Jul 31, 2025 | Apr 30, 2025 | Oct 31, 2024 | Jul 31, 2024 |
|---|---|---|---|---|---|---|
| Revenue | 11.13bn | 10.26bn | 10.24bn | 9.83bn | 9.44bn | 9.33bn |
| Cost of revenue | 2.57bn | 2.26bn | 2.24bn | 2.27bn | 2.11bn | 2.16bn |
| Gross profit | 8.56bn | 8.00bn | 7.99bn | 7.56bn | 7.34bn | 7.17bn |
| Research and development | 1.63bn | 1.43bn | 1.48bn | 1.46bn | 1.36bn | 1.35bn |
| Selling, general and administrative | 740m | 667m | 734m | 697m | 711m | 711m |
| Operating expenses | 6.22bn | 5.82bn | 5.66bn | 5.62bn | 5.45bn | 5.38bn |
| Operating income | 2.35bn | 2.19bn | 2.33bn | 1.94bn | 1.89bn | 1.78bn |
| Pre-tax income | 2.72bn | 2.51bn | 2.41bn | 1.97bn | 1.75bn | 1.84bn |
| Income tax | 614m | 426m | 519m | 433m | 219m | 408m |
| Net income | 2.11bn | 2.09bn | 1.89bn | 1.54bn | 1.53bn | 1.43bn |
| Earnings per share | 2.43 | 2.20 | 1.97 | 1.61 | 1.60 | 1.48 |
| Earnings per share, diluted | 2.42 | 2.19 | 1.96 | 1.59 | 1.58 | 1.47 |
| Weighted average shares | 868m | 948m | 956m | 960m | 956m | 964m |
| Weighted average shares, diluted | 871m | 952m | 962m | 970m | 965m | 973m |
| Metric | Apr 30, 2026 | Jan 31, 2026 | Oct 31, 2025 | Jul 31, 2025 | Apr 30, 2025 | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 8.94bn | 7.33bn | 8.98bn | 10.37bn | 10.93bn | 8.85bn | 8.00bn | 7.68bn |
| Receivables | 5.08bn | 14.34bn | 5.47bn |
| Metric | Apr 30, 2026 | Oct 31, 2025 | Jul 31, 2025 | Apr 30, 2025 | Oct 31, 2024 | Jul 31, 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | 6.70bn | 2.32bn | 740m | 6.48bn | 1.98bn | 892m |
| Depreciation and amortisation | 985m | 851m | 817m | 843m | 814m | 907m |
Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)
| 5.60bn |
| 4.35bn |
| 11.95bn |
| 4.74bn |
| 5.39bn |
| Current assets | 21.61bn | 28.22bn | 21.06bn | 25.33bn | 25.87bn | 29.73bn | 21.43bn | 21.86bn |
| Goodwill | 59.29bn | 57.94bn | 52.46bn | 51.44bn | 51.28bn | 51.28bn | 49.09bn | 48.94bn |
| Total assets | 106.68bn | 112.31bn | 95.14bn | 97.57bn | 98.61bn | 102.93bn | 91.40bn | 92.18bn |
| Current liabilities | 27.50bn | 37.12bn | 21.41bn | 22.53bn | 24.20bn | 27.98bn | 19.38bn | 21.00bn |
| Long-term debt | 39.28bn | 10.44bn | 8.44bn | 8.44bn | 8.44bn | 8.43bn | 8.43bn | 8.43bn |
| Total liabilities | 72.45bn | 53.16bn | 35.12bn | 36.25bn | 37.94bn | 41.76bn | 32.87bn | 34.55bn |
| Equity | 34.24bn | 59.14bn | 60.02bn | 61.33bn | 60.67bn | 61.17bn | 58.53bn | 57.63bn |
| Shares outstanding | — | 929m | — | — | — | 962m | — | — |
| Shares issued | — | 1.07bn | — | — | — | 1.06bn | — | — |
| Share-based compensation | 857m | 819m | 793m | 814m | 820m | 810m |
| Capital expenditure | 145m | 139m | 135m | 179m | 204m | 137m |
| Investing cash flow | −2.18bn | 519m | 1.17bn | −1.57bn | −217m | 2.64bn |
| Dividends paid | 365m | 395m | 399m | 402m | 382m | 384m |
| Share buybacks | 27.25bn | 3.80bn | 2.23bn | 2.63bn | 1.29bn | 4.34bn |
| Financing cash flow | −2.92bn | −4.24bn | −2.50bn | −2.92bn | −1.45bn | −5.80bn |